HHLR ADVISORS, LTD. - Q3 2021 holdings

$7.65 Billion is the total value of HHLR ADVISORS, LTD.'s 85 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 420.0% .

 Value Shares↓ Weighting
LEGN BuyLEGEND BIOTECH CORPsponsored ads$558,937,000
+1994.7%
11,054,925
+1600.8%
7.31%
+2558.2%
IMAB BuyI MABsponsored ads$520,685,000
-6.3%
7,182,850
+8.6%
6.81%
+19.1%
NewON HLDG AGnamen akt a$481,289,00015,973,750
+100.0%
6.30%
JD BuyJD.COM INCspon adr cl a$344,390,000
+17.2%
4,767,307
+29.4%
4.50%
+48.8%
CRM BuySALESFORCE COM INC$340,158,000
+22.5%
1,254,176
+10.4%
4.45%
+55.7%
NewCYTEK BIOSCIENCES INC$187,488,0008,757,030
+100.0%
2.45%
SE NewSEA LTDsponsord ads$105,181,000330,000
+100.0%
1.38%
NewERASCA INC$100,206,0004,722,221
+100.0%
1.31%
ILMN NewILLUMINA INC$67,986,000167,614
+100.0%
0.89%
CPNG NewCOUPANG INCcl a$60,721,0002,180,272
+100.0%
0.79%
NewTANGO THERAPEUTICS INC$56,556,0004,373,982
+100.0%
0.74%
NewMEMBERSHIP COLLECTIVE GROUP$46,128,0003,708,041
+100.0%
0.60%
ALGS BuyALIGOS THERAPEUTICS INC$36,682,000
-16.9%
2,365,064
+9.2%
0.48%
+5.7%
LI NewLI AUTO INCsponsored ads$28,393,0001,080,000
+100.0%
0.37%
PACB NewPACIFIC BIOSCIENCES CALIF IN$23,277,000911,039
+100.0%
0.30%
NewRALLYBIO CORP$15,887,000903,673
+100.0%
0.21%
COIN NewCOINBASE GLOBAL INC$15,924,00070,000
+100.0%
0.21%
NewHIPPO HLDGS INC$12,972,0002,771,691
+100.0%
0.17%
NewTSCAN THERAPEUTICS INC$10,700,0001,282,976
+100.0%
0.14%
NewSURROZEN INC$8,496,0001,200,000
+100.0%
0.11%
AMD NewADVANCED MICRO DEVICES INC$7,203,00070,000
+100.0%
0.09%
NewCHINA JO-JO DRUGSTORES INC$3,079,0004,840,000
+100.0%
0.04%
DNUT NewKRISPY KREME INC$2,634,000188,638
+100.0%
0.03%
NewCCC INTELLIGENT SOLUTIONS HL$2,102,000200,000
+100.0%
0.03%
NewSURROZEN INC*w exp 08/01/203$456,000399,999
+100.0%
0.01%
NewCCC INTELLIGENT SOLUTIONS HL*w exp 07/30/202$93,00040,000
+100.0%
0.00%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings